Seoul St. Mary's Hospital and Singapore General Hospital Join Thermo Fisher Scientific's Next-Generation Sequencing Center of Excellence Program

Seoul St. Mary’s Hospital and Singapore General Hospital Join Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program Newest partners announced during company’s Global Strategic Partner Summit in Boston BOSTON, Oct. 2, 2018 /PRNewswire/ — Seoul St. Mary’s Hospital, part of Catholic Medical Center (CMC) in South Korea, and Singapore General Hospital are the newest... Read more

Thermo Fisher Scientific Announces Sixth Licensing Agreement for B•R•A•H•M•S PCT

Thermo Fisher Scientific Announces Sixth Licensing Agreement for B•R•A•H•M•S PCT Siemens Healthineers Recent FDA Clearance of the Atellica IM B•R•A•H•M•S PCT Assay Extends Access of Procalcitonin to More U.S. Laboratories WALTHAM, Mass., Oct. 2, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., today announced the sixth licensing agreement for its B·R·A·H·M·S PCT (procalcitonin) biomarker that provides information... Read more

PharmaFluidics Facilitates Ultra-high-resolution Proteomics Analysis Through Agreement with Thermo Fisher Scientific

PharmaFluidics NV, an innovative bio-analytical chromatography company, announced today that it entered into a Partnership Agreement with Thermo Fisher Scientific Inc, a global Life Sciences Tools and Instruments leader. The agreement empowers PharmaFluidics to sell Thermo Fisher custom-made EASY-Spray™ transfer lines, in combo sets with PharmaFluidics’ own line of µPAC™ chromatography micro-Chips, to constitute an... Read more

Agilent Brings Greater Clarity and Speed to Chemical Imaging

Agilent Brings Greater Clarity and Speed to Chemical Imaging Breakthrough System Takes Brand New Approach SANTA CLARA, Calif., October 1, 2018 Agilent Technologies Inc. (NYSE: A) today introduced a new approach to chemical imaging that will bring greater clarity and unprecedented speed to pharmaceutical, biomedical, food, and materials science. The Agilent 8700 Laser Direct Infrared... Read more

PerkinElmer Receives FDA Clearance for NeoBase™ 2 Non-Derivatized Tandem Mass Spectrometry Kit

In vitro diagnostic solution tests newborn babies for a variety of metabolic disorders with a single dried blood spot card WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its NeoBase™ 2 Non-Derivatized MSMS Kit has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). Used with... Read more

Thermo Fisher Scientific Showcases Innovations in Proteomic Research at HUPO 2018

Thermo Fisher Scientific Showcases Innovations in Proteomic Research at HUPO 2018 ORLANDO, Fla., Oct. 1, 2018 /PRNewswire/ — HUPO 2018 – Demonstrating its commitment to advancing the performance of protein analysis, Thermo Fisher Scientific is showcasing its latest solutions and technologies at the 17th Human Proteome Organization (HUPO) World Congress (booth #401), September 30-October 3 at the... Read more

Bruker Announces Breakthrough Proteomics and Lipidomics Workflow Advances for the timsTOF™ Pro at HUPO 2018

ORLANDO, Fla., Oct. 1, 2018 /PRNewswire/ — At the 17th Annual World Congress of the Human Proteome Organization (www.hupo.org), Bruker announces next-generation workflows for the timsTOF Pro mass spectrometer. Introduced a year ago at the HUPO conference in Dublin, this revolutionary mass spectrometry platform is a new enabling technology for ultra-high sensitivity proteomics and large-cohort clinical... Read more

Illumina Announces Conversion Period for 0% Convertible Senior Notes due 2019 and 0.5% Convertible Senior Notes due 2021

SAN DIEGO–(BUSINESS WIRE)–Sep. 28, 2018– Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “Company”) today notified holders of its 0% Convertible Senior Notes due 2019 (the “2019 Notes”) and its 0.5% Convertible Senior Notes due 2021 (the “2021 Notes” and, together with the 2019 Notes, the “Notes”) that the Notes will become convertible into Illumina common stock at the option... Read more

PerkinElmer and DBT- ICT Inaugurate “explorer™ G3 Project” – an Advanced High-Throughput Screening Facility

MUMBAI, India–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, collaborated with Institute of Chemical Technology (ICT) to open “explorerTM G3 Project,” an advanced high-throughput screening facility at DBT-ICT Centre for Energy Biosciences, Mumbai. The facility was inaugurated by Dr. Renu Swarup, Secretary, Department of Biotechnology (DBT), Union Ministry for Science... Read more

Bruker Launches the G4 ICARUSTM Series 2 Combustion Analyzer for High-Sensitivity Carbon and Sulfur Analysis

G4 ICARUS Series 2 – High-performance carbon and sulfur analyzer KARLSRUHE, Germany – September 27, 2018 – Bruker today announces the launch of the new G4 ICARUSTM Series 2, a versatile, high-sensitivity combustion analyzer for carbon and sulfur concentration measurements in inorganic samples. The G4 ICARUS Series 2extends Bruker’s line of compact, high-efficiency and low-maintenance combustion analyzers by introducing... Read more